N.I.H. Director Will Temporarily Run C.D.C. in Leadership Shake-Up / NYT

Sheryl Gay Stolberg / nytimes - Dr. Jay Bhattacharya will serve as acting director of the Centers for Disease Control and Prevention until President Trump appoints a permanent director.

#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety

CDC vaccine committee cancels meeting

19 days / beckershospitalreview / Erica Cerutti

Amid CDC upheaval, key vaccine panel won't convene February meeting

19 days / fiercehealthcare

NIH director named acting CDC chief amid leadership shake-ups

20 days / beckershospitalreview / Ella Jeffries

NIH Director Jay Bhattacharya to take over as temporary CDC chief: media reports

20 days / fiercehealthcare

N.I.H. Director Will Temporarily Run C.D.C. in Leadership Shake-Up

20 days / nytimes / Sheryl Gay Stolberg

Wednesday, February 18, 2026, 7:22 pm / permalink 19391 / 5 stories in 20 days

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine / NYT

Christina Jewett and Rebecca Robbins / nytimes - Moderna said it had held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda #vaccinesafety

Potential Eylea competitor disappoints; FDA to review Moderna’s flu vaccine; Another rare disease rejection; and more

18 days / endpoints / Max Gelman

FDA's abrupt flip-flop on Moderna's mRNA flu shot highlights growing risks to drug-makers of investing in vaccines

19 days / medicalxpress

What the Health? From KFF Health News: Turnarounds and Shake-Ups

19 days / kffhealthnews

Study shows low vaccination rates among expectant mothers in Norway against COVID-19, influenza

20 days / medicalxpress

FDA reverses course; agrees to review Moderna flu vaccine

21 days / beckershospitalreview / Erica Cerutti

Reversal on Moderna's flu application follows atypical path through FDA

21 days / endpoints / Zachary Brennan

Moderna says the FDA will consider its new flu shot after resolving a public dispute

21 days / abcnews

In reversal, US agrees to review new Moderna flu shot

21 days / medicalxpress

FDA reverses course on Moderna’s flu vaccine

21 days / healthcaredive / Delilah Alvarado

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

21 days / nytimes / Christina Jewett and Rebecca Robbins

FDA reverses course, will review Moderna’s flu vaccine

21 days / endpoints / Max Bayer

Wednesday, February 18, 2026, 9:23 am / permalink 19353 / 11 stories in 21 days

StackHealth Time Machine

Outgoing Stories

Judge orders Leapfrog to remove safety grades for five Florida hospitals 3 stories in 21.1 hours

Daily multivitamin slows epigenetic aging in randomized COSMOS analysis 4 stories in 40.1 hours

Engineered CAR‑T cells secreting VEGF‑neutralizing scFvs boost solid‑tumor activity 6 stories in 54.2 hours

White House briefing triggered rapid drops in acetaminophen use in ERs 2 stories in 58.1 hours

MUSC Health buys large South Carolina multispecialty practice for $111M 4 stories in 58.2 hours

Eli Lilly launches Employer Connect to broaden GLP‑1 coverage 16 stories in 83.2 hours

Analysis finds small patient group drives majority of admissions and costs 2 stories in 83.2 hours

Springing forward worsens sleep and sparks health complaints 8 stories in 87.2 hours

Cancer Grand Challenges awards five teams bold funding for cancer research 67 stories in 94.2 hours

Belzutifan combinations highlighted at ASCO GU improve RCC outcomes 3 stories in 96.2 hours

More StackHealth

Bluesky: